Why the study?
Does nicotinic acid reduce atherosclerosis through lipid-lowering and direct immunomodulatory pathways?
Does nicotinic acid reduce atherosclerosis through lipid-lowering and direct immunomodulatory pathways?
Nicotinic acid offers potent anti-atherosclerotic benefits through both lipid-lowering and novel direct immunomodulatory pathways, despite limitations like flushing and hepatotoxicity.
Authors
No takes yet. Share an insight, caveat, or question.
May inform GPR109A-targeted therapies; leaves open clinical utility pending randomized trials.
Montecucco et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: